Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian G Baker

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|January 19, 2005
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptorsJillian G Baker
Pharmacology Research & Perspectives|January 4, 2026
Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-BlockerJillian G Baker
Molecular Pharmacology|September 1, 2005
Evidence for a secondary state of the human beta3-adrenoceptorJillian G Baker
British Journal of Pharmacology|July 2, 2010
The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptorsJillian G Baker
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2005
Site of action of beta-ligands at the human beta1-adrenoceptorJillian G Baker
Plos One|December 15, 2010
A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptorsJillian G Baker
BMC Pharmacology|June 10, 2008
Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cellsJillian G Baker
Thorax|April 11, 2020
Case for continuing community NIV and CPAP during the COVID-19 epidemicJillian G Baker, Milind Sovani
Trends in Pharmacological Sciences|July 17, 2007
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimatesJillian G Baker, Stephen J Hill
Thorax|December 9, 2016
β-Blockers, heart disease and COPD: current controversies and uncertaintiesJillian G Baker, Robert G Wilcox
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|January 19, 2005
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptorsJillian G Baker
Pharmacology Research & Perspectives|January 4, 2026
Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-BlockerJillian G Baker
Molecular Pharmacology|September 1, 2005
Evidence for a secondary state of the human beta3-adrenoceptorJillian G Baker
British Journal of Pharmacology|July 2, 2010
The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptorsJillian G Baker
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2005
Site of action of beta-ligands at the human beta1-adrenoceptorJillian G Baker
Plos One|December 15, 2010
A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptorsJillian G Baker
BMC Pharmacology|June 10, 2008
Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cellsJillian G Baker
Thorax|April 11, 2020
Case for continuing community NIV and CPAP during the COVID-19 epidemicJillian G Baker, Milind Sovani
Trends in Pharmacological Sciences|July 17, 2007
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimatesJillian G Baker, Stephen J Hill
Thorax|December 9, 2016
β-Blockers, heart disease and COPD: current controversies and uncertaintiesJillian G Baker, Robert G Wilcox
Pageof 6